NYSEARCA:PPHCRRD VanEck Vectors Pharmaceutical ETF (PPHCRRD) Price, Holdings, & News → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free PPHCRRD Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AAssets Under Management$173.85 millionDividend YieldN/ANet Expense Ratio0.00% Stock AnalysisStock Analysis Get VanEck Vectors Pharmaceutical ETF alerts: Email Address About VanEck Vectors Pharmaceutical ETFRead More Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report PPHCRRD ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PPHCRRD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Vectors Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details Issuer Fund NameVanEck Vectors Pharmaceutical ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PPHCRRD Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings0 Fund Statistics Assets Under Management$173.85 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding SharesN/ABetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him VanEck Vectors Pharmaceutical ETF ExpensesTypePPHCRRDNYSEARCA ETFsAll ETFsManagement Fee0.00%0.50%0.51%Other Expenses0.00%0.64%0.58%Total Expense0.00%0.74%0.70%Fee Waiver0.00%-0.68%-0.57%Net Expense0.00%0.57%0.58% VanEck Vectors Pharmaceutical ETF (PPHCRRD)Full Holdings Details Similar ETFsHillman Value No LoadNYSEARCA:HCMAXVanEck Vectors Rare Earth/Strategic Metals ETFNYSEARCA:REMXCRRDHartford Quality Value ETFNYSEARCA:QUVUVanEck Vectors CEF Municipal Income ETFNYSEARCA:XMPTCRRDRiverNorth Managed Duration Municipal Income Fund IINYSEARCA:RMMZ PPHCRRD ETF - Frequently Asked Questions How do I buy shares of VanEck Vectors Pharmaceutical ETF? Shares of PPHCRRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:PPHCRRD) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Vectors Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
